Diluvio, G., Del Gaudio, F., Giuli, M. V., Franciosa, G., Giuliani, E., Palermo, R., . . . Checquolo, S. (2018). NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. Oncogenesis.
Chicago Style citaatDiluvio, Giulia, et al. "NOTCH3 Inactivation Increases Triple Negative Breast Cancer Sensitivity to Gefitinib By Promoting EGFR Tyrosine Dephosphorylation and Its Intracellular Arrest." Oncogenesis 2018.
MLA citatieDiluvio, Giulia, et al. "NOTCH3 Inactivation Increases Triple Negative Breast Cancer Sensitivity to Gefitinib By Promoting EGFR Tyrosine Dephosphorylation and Its Intracellular Arrest." Oncogenesis 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.